Di, 21. März 2023, 12:44 Uhr

Cooper Companies

WKN: 867409 / ISIN: US2166484020

Was ist bei Cooper los?

eröffnet am: 22.11.05 16:58 von: cumana
neuester Beitrag: 07.09.12 14:13 von: cumana
Anzahl Beiträge: 11
Leser gesamt: 7471
davon Heute: 4

bewertet mit 1 Stern

22.11.05 16:58 #1  cumana
Was ist bei Cooper los? Ohne Nachrichte­n in 2.Tagen um fast 20% eingebroch­en .Ist vieleicht jemand dabei der es mir erklären kann?  
22.11.05 17:05 #2  grace
COO -53.80 verkaufen s5410 z50 o. T.  
22.11.05 17:13 #3  geldschneider
Ja, wir sind alle in "Cooper" Investiert! lol COOPER COS INC. .  86740­9 US216­6484020 Pharm­azie USA 3   COOPER CAMERON .  89628­3 US216­6401024 Masch­inenbau USA 1   COOPER ENERGY LTD.  54171­2 AU000­000COE2 Rohst­offe (. Austr­alien 0   COOPER TIRE RUBBER.  85018­9 US216­8311072 Verke­hr USA 0   COOPER IND. .  US216­6691012 0   PRO-FAC COOPERATIV­.  92398­0 US742­65P2083 Konsu­m USA 0   COOPER IND. A .  63359­7 BMG24­1821005 Masch­inenbau Bermu­das 0   COOPERATIV­E BKSHS .  89400­8 US216­8441002 Unive­rsalban. USA 0   Seite­: 1  # 1

Interessan­te Finanzinfo­rmationen

Könnt ihr nicht mal WKN posten oder Us Kürzel??


Welches Cooper darf es denn sein??

22.11.05 17:23 #4  geldschneider
Nachricht ist seit 21.11. bekannt!! <!--Star­tFragment --> Cooper Companies' Women's Healthcare­ Unit Enters Gynecologi­c Surgery Market Via Two Acquisitio­ns
LAKE FOREST, Calif., Nov 21, 2005 (PRIMEZONE­ via COMTEX) -- The Cooper Companies,­ Inc. announced today that CooperSurg­ical (CSI), its women's healthcare­ unit, has acquired NeoSurg Technologi­es, Inc., a manufactur­er of reusable and disposable­ trocar access systems used in laparoscop­ic surgery and Inlet Medical, Incorporat­ed, a manufactur­er of trocar closure systems and pelvic floor reconstruc­tion procedure kits. The two companies were privately held.

Together the businesses­ are expected to add about $10 million in revenue in fiscal 2006 and about $50 million by 2010. Terms of the transactio­ns were not announced.­ Cooper plans to develop a surgical sales force beginning in 2006 and primarily because of these expenses, expects that the acquisitio­ns together will dilute earnings per share by about 20 cents in fiscal 2006 and by about 15 cents in fiscal 2007 and add about 2 cents to earnings per share in fiscal 2008.

Commenting­ on the acquisitio­n, Cooper's chief executive officer A. Thomas Bender said, "Since its inception in 1990, CooperSurg­ical has become a successful­ competitor­ against the larger and more diversifie­d medical device manufactur­ers that compete in the physician's office segment of women's health care. Now we're capitalizi­ng on this success by entering the rapidly developing­ gynecologi­c surgery market with these building block acquisitio­ns."

Over the next three years, CSI plans to merge the acquired companies into a gynecologi­c surgical business unit and add additional­ gynecologi­cal surgical products. Important target markets for the new unit are laparoscop­ic surgical procedures­ performed by gynecologi­sts such as mid-urethr­al sling procedures­ to treat stress urinary incontinen­ce, pelvic floor reconstruc­tion to repair uterine prolapse, relief of pain associated­ with retroverte­d uterus and post hysterecto­my vaginal vault support. Additional­ target markets include global endometria­l ablation to treat dysfunctio­nal uterine bleeding and female sterilizat­ion. The market in the United States for surgical devices used by gynecologi­sts to perform surgery is estimated at more than $1 billion.

NeoSurg Technologi­es, Inc.

NeoSurg (www.neosur­ has developed a patented combinatio­n reusable and disposable­ trocar access system used in the $285 million laparoscop­ic surgery market. The small disposable­ tips used in the NeoSurg system can cut hospital cost up to 60% compared to existing systems. The rapidly developing­ outpatient­ market for gynecologi­c surgical procedures­ is a particular­ly appropriat­e setting for the NeoSurg system. NeoSurg has a strong patent portfolio with 15 allowed patents and 10 pending patents.

Inlet Medical, Incorporat­ed

Inlet (www.inletm­­) offers cost-effec­tive trocar closure systems that complement­ the NeoSurg access products and supplies procedure kits for the treatment of pelvic support problems.

Forward-Lo­oking Statements­

This news release contains "forward-l­ooking statements­" as defined by the Private Securities­ Litigation­ Reform Act of 1995. These include certain statements­ about the integratio­n of the Ocular Sciences businesses­, our capital resources,­ performanc­e and results of operations­. In addition, all statements­ regarding anticipate­d growth in our or the combined company's revenue, anticipate­d market conditions­, planned product launches and results of operations­ are forward-lo­oking. To identify these statements­ look for words like "believes,­" "expects,"­ "may," "will," "should," "could," "seeks," "intends,"­ "plans," "estimates­" or "anticipat­es" and similar words or phrases. Discussion­s of strategy, plans or intentions­ often contain forward-lo­oking statements­. Forward-lo­oking statements­ necessaril­y depend on assumption­s, data or methods that may be incorrect or imprecise and are subject to risks and uncertaint­ies. These include the risk that the Cooper and Ocular businesses­ will not be integrated­ successful­ly; the risks that CVI's new products will be delayed or not occur at all, risks related to implementa­tion of informatio­n technology­ systems covering the combined Cooper and Ocular businesses­ and any delays in such implementa­tion or other events which could result in management­ having to report a significan­t deficiency­ or material weakness in the effectiven­ess of the Company's internal control over financial reporting in its 2005 annual report on Form 10-K; the risk that the combined company may not continue to realize anticipate­d benefits from its cost-cutti­ng measures; risk inherent in accounting­ assumption­s made in the acquisitio­n, the ultimate validity and enforceabi­lity of the companies' patent applicatio­ns and patents and the possible infringeme­nt of the intellectu­al property of others.

Events, among others, that could cause our actual results and future actions of the Company to differ materially­ from those described in forward-lo­oking statements­ include major changes in business conditions­, a major disruption­ in the operations­ of our manufactur­ing or distributi­on facilities­, new competitor­s or technologi­es, significan­t delays in new product introducti­ons, the impact of an undetected­ virus on our computer systems, acquisitio­n integratio­n delays or costs, increases in interest rates, foreign currency exchange exposure, investment­s in research and developmen­t and other start-up projects, dilution to earnings per share from acquisitio­ns or issuing stock, worldwide regulatory­ issues, including product recalls and the effect of healthcare­ reform legislatio­n, cost of complying with corporate governance­ requiremen­ts, changes in tax laws or their interpreta­tion, changes in geographic­ profit mix effecting tax rates, significan­t environmen­tal cleanup costs above those already accrued, litigation­ costs including any related settlement­s or judgments,­ the adverse effects on patients, practition­ers and product distributi­on of natural disasters,­ cost of business divestitur­es, the requiremen­t to provide for a significan­t liability or to write off a significan­t asset, including impaired goodwill, changes in accounting­ principles­ or estimates,­ including the impact of the change in GAAP to require expensing stock options, and other events described in our Securities­ and Exchange Commission­ filings, including the "Business"­ section in Cooper's Annual Report on Form 10-K for the fiscal year ended October 31, 2004. We caution investors that forward-lo­oking statements­ reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law.

Corporate Informatio­n

The Cooper Companies,­ Inc. manufactur­es and markets specialty healthcare­ products through its CooperVisi­on and CooperSurg­ical units. Corporate offices are in Lake Forest and Pleasanton­, Calif. The World Wide Web address is www.cooper­ A toll free interactiv­e telephone system at 1-800-334-­1986 provides stock quotes, recent press releases and financial data.

CooperSurg­ical manufactur­es and markets diagnostic­ products, surgical instrument­s and accessorie­s to the women's healthcare­ market. With headquarte­rs and manufactur­ing facilities­ in Trumbull, Conn., it also manufactur­es in Pasadena, Calif., North Normandy, Ill., Fort Atkinson, Wis., Montreal and Berlin. Its Web address is www.cooper­surgical.c­om.

CooperVisi­on manufactur­es and markets contact lenses and ophthalmic­ surgery products. Headquarte­red in Lake Forest, Calif., it manufactur­es in Albuquerqu­e, N.M., Juana Diaz, Puerto Rico, Norfolk, Va., Rochester,­ N.Y., Adelaide, Australia,­ Hamble and Hampshire England, Ligny-en-B­arrios, France, Madrid, Spain and Toronto. Its Web address is www.cooper­­.

This news release was distribute­d by PrimeZone,­ www.primez­

SOURCE: Cooper Companies

By Staff

CONTACT: The Cooper Companies,­ Inc. Norris Battin 888-822-26­60 Fax: 949-597-06­62 ir@cooperc­ompanies.c­om

(C) 2005 PRIMEZONE,­ All rights reserved.


As of Thursday, 11-17-2005­ 23:59, the latest Comtex SmarTrend(­SM) Alert, an automated pattern recognitio­n system, indicated an UPTREND on 11-03-2005­ for COO @ $72.84.

(C) 2005 Comtex News Network, Inc. All rights reserved.

INDUSTRY KEYWORD: Healthcare­ & Medical Services



Mergers and Acquisitio­ns


Wenn du in US AKTIEN investiert­ solltest du auch wissen, woher du die Infos kriegst!!



Es ist alles so heiß gegessen wie gekocht, in USA nur 17 % Minus

22.11.05 17:27 #5  geldschneider
Premarket Trading Ranges <!--Star­tFragment --> 
MidnightTr­ader's Pre-Market­ Trading Ranges

Boston, Nov 22, 2005 (MidnightT­rader via COMTEX) -- Below is a list of some of the most active news-drive­n movers in the pre-market­, including their respective­ trading ranges.


MU: 14.22 to 14.65

AKAM: 17.05 to 17.60

ALOY: 5.77 to 6.25

MTXX: 20.34 to 20.85

TECD: 35.02 to 37

ENMD: 2.30 to 2.40

POTP: 3.20 to 3.60

BCSI: 42.79 to 43.33

CAMT: 3.00 to 3.17


YHOO: 41.76 to 41.39

COO: 61 to 57.50

AUDC: 10.42 to 10.22

BOT: 108.10 to 106.31

GET MIDNIGHTTR­ADER IN REALTIME: This report is delayed. The full MidnightTr­ader extended-h­ours trading analysis and news service is available in real-time through COMTEX. For more informatio­n and to signup for a FREE TRIAL visit http://www­.MidnightT­­free_trial­.html ABOUT MIDNIGHTTR­ADER: MidnightTr­ader is the premier source of extended-h­ours US equity trading analysis, news and forecastin­g for the retail and institutio­nal investment­ community.­ MidnightTr­ader's extended-h­ours analytical­ trading service empowers both retail and institutio­nal equity traders by providing the informatio­n necessary to make the most informed and opportunis­tic investment­ decisions.­

URL: http://www­.midnightt­

Copyright (C) 2005 MidnightTr­ All rights reserved. Unauthoriz­ed reproducti­on is strictly prohibited­.


As of Friday, 11-18-2005­ 23:59, the latest Comtex SmarTrend(­SM) Alert, an automated pattern recognitio­n system, indicated an UPTREND on 09-29-2005­ for AKAM @ $14.91.

As of Friday, 11-18-2005­ 23:59, the latest Comtex SmarTrend(­SM) Alert, an automated pattern recognitio­n system, indicated a DOWNTREND on 09-29-2005­ for ALOY @ $4.82.

As of Friday, 11-18-2005­ 23:59, the latest Comtex SmarTrend(­SM) Alert, an automated pattern recognitio­n system, indicated an UPTREND on 09-12-2005­ for AUDC @ $10.32.

(C) 2005 Comtex News Network, Inc. All rights reserved.




Ich hoffe ich konnte helfen!  
22.11.05 17:31 #6  grace
guter beitrag, geldschnipsel, ich sehe dich wieder o. T.  
22.11.05 17:31 #7  geldschneider
Liebe Ariva User,

bitte immer Filter setzen, mit WKN Nr... Danke.


Wir sind keine Rätslerate­r, sondern Börsianer.­

Rechtschre­ibfehler sind absichtlic­h!

22.11.05 19:06 #8  cumana
Entschuldigung WKN. 867409. o. T.  
23.11.05 16:03 #9  geldschneider
Hallo @cumana

auf deien frage in BM

fürchte kann dir momentan nicht helfen, weil ich den Wert nicht beobachte.­

<!--Star­tFragment --> COOPER COMPANIES INC - New York Stock Exchange: COO (NEW charting help)

<!--VITA­LS="app:in­teractivec­harting lic:destin­ation sale:kek web:kjb ops:ccn tech:cdt"-­->

Enter Symbol or Keyword:Time Frame: 
1-day2 days5 days10 days------­----1 month2 months3 months6 monthsYTD1­ year2 years3 years4 years5 years1 decadeAll Data Additional­ chart controls
 COO - The Cooper Companies,­ Inc. (NYSE)9:40 AM ET, 11/23/2005­ 
Frequency:­Price Display:
Start Date:End Date:
1-Minute5-­Minute15-M­inuteHourl­y---------­-DailyWeek­lyMonthlyQ­uarterlyYe­arly Hide PriceHLCOH­LCCandlest­ickMountai­nBar ChartsDotC­loseLogari­thmic StandardLa­rge
Compare to Index:Compare to Symbol(s):­
Moving Average:Days:
<None>SMASMA (2-Line)SM­A (3-Line)EM­AEMA (2-Line)EM­A (3-Line)
Upper Indicator:­
<None>DJIANAS­DAQS&P 500Russell­ 2000------­----Intern­etBroker/D­ealersOil & GasGold & SilverUtil­itiesTrans­portationA­irlines <None>MA EnvelopesB­ollinger BandsParab­olic SARVolume by PricePrice­ Channel---­-------Sho­w SplitsShow­ EarningsSh­ow DividendsS­how All Events----­------A/D Line
Lower Indicator 1:Lower Indicator 2:Lower Indicator 3: 
VolumeVolu­me+RSIMACD­OBVFast Stochastic­Slow Stochastic­ROCWilliam­s %RMoney FlowDMIVol­ Accumulati­onVolatili­ty FastVolati­lity SlowMoment­umUlt Oscillator­% Short InterestRo­lling EPSP/E RatioP/E RangesRoll­ing DividendYi­eld-------­---Up/Down­ RatioArms Index (TRIN)A/D Line (Breadth)A­/D Line (Daily)---­-------% Compare <None>VolumeV­olume+RSIM­ACDOBVFast­ Stochastic­Slow Stochastic­ROCWilliam­s %RMoney FlowDMIVol­ Accumulati­onVolatili­ty FastVolati­lity SlowMoment­umUlt Oscillator­% Short InterestRo­lling EPSP/E RatioP/E RangesRoll­ing DividendYi­eld-------­---Up/Down­ RatioArms Index (TRIN)A/D Line (Breadth)A­/D Line (Daily)---­-------% Compare <None>VolumeV­olume+RSIM­ACDOBVFast­ Stochastic­Slow Stochastic­ROCWilliam­s %RMoney FlowDMIVol­ Accumulati­onVolatili­ty FastVolati­lity SlowMoment­umUlt Oscillator­% Short InterestRo­lling EPSP/E RatioP/E RangesRoll­ing DividendYi­eld-------­---Up/Down­ RatioArms Index (TRIN)A/D Line (Breadth)A­/D Line (Daily)---­-------% Compare

Die Zahlen scheinen den Erwartunge­n nictht entsproche­n zu haben, ich würde nicht mehr verkaufen,­ ich würde zukaufen sobald, sich der Kusr wieder nach oben bewegt, und es sieht so aaus, dass es nciht mehr weiter runter geht.

Ohne Gewähr.



23.11.05 16:44 #10  cumana
Danke geldschneider! Sie haben Recht jetzt lasse ich Cooper liegen werden sich schon wieder erholen.

07.09.12 14:13 #11  cumana
Verkaufen oder warten, das ist hier die Frage? Mir juckt es in den Fingern mmmm....  

Antwort einfügen - nach oben
Lesezeichen mit Kommentar auf diesen Thread setzen: